Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, synthesis editing, and related services. The B Medical Systems segment manufactures and distributes temperature-controlled storage and transportation solutions to governments, health institutions, and non-government organizations. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Azenta Inc.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Azenta (AZTA – Research Report) and Boston Scientifi...

Analysts Are Bullish on Top Healthcare Stocks: Azenta (AZTA), Boston Scientific (BSX)

The latest announcement is out from Azenta ( ($AZTA) ). On December 10, 2025, Azenta, Inc. announced a $250 million share repurchase program author...

Azenta Announces $250 Million Share Repurchase Program

In a report released today, David Stanton from Jefferies maintained a Buy rating on Azenta, with a price target of $42.00. According to TipRanks, S...

Jefferies Keeps Their Buy Rating on Azenta (AZTA)

Azenta, Inc. ( ($AZTA) ) has released its Q4 earnings. Here is a breakdown of the information Azenta, Inc. presented to its investors. Azenta, Inc....

Current Quarter	$0.11	Next Quarter	$0.16
Current Year	$0.75	Next Year	$1.05
QoQ Growth	+45.5%	YoY Growth	+40.0%
3Y EPS CAGR	-59.7%	Target Price	$37.83
Consensus	Buy	Upside	+7.2%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	AZTA	$35.30	-5.87%	632.24K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	AZTA	$35.30	-5.9%	632.24K
3
4
5
6

AZTA

AZTA

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Azenta Inc. Data in Excel

Get Azenta Inc. Data in Excel